The vascular endothelial growth factor-2549 insertion/deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese

DNA and Cell Biology

Volumn 29, Issue 7, 2010, Pages 393-396

  He, Yan ^a   Ni, Jianqiang ^a   Chen, Shougong ^a   Jiang, Yuting ^a   Jia, Shasha ^a   Gao, Yuzhen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; DRINKING BEHAVIOR; FEMALE; GENE DELETION; GENE INSERTION; GENETIC SUSCEPTIBILITY; GENOTYPE; GROUPS BY AGE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SMOKING;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; NEOPLASM STAGING; NEOPLASMS; POLYMORPHISM, GENETIC; SEQUENCE DELETION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

HEPATITIS B VIRUS;

EID: 77954912150     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.1015     Document Type: Article

References (21)

1. Akiri, G., Nahari D., Finkelstein, Y., Le, S.Y., Elroy-Stein, O., and Levi, B.Z. (1998). Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Onco-gene 17, 227-236.
2. Allen, R.C., Graves, G., and Budowle, B. (1989). Polymerase chain reaction amplification products separated on rehydrat-able polyacrylamide gels and stained with silver. Biotechni-ques 7, 736-744.
3. Awata, T., Inoue, K., Kurihara, S., Ohkubo, T., Watanabe, M., Inukai, K., Inoue, I., and Katayama, S. (2002). A common polymorphism in the 5-untranslated region of the VEGF gene is associated with diabetic retinopathy in type II diabetes. Diabetes 5, 1635-1639.
4. Chen, C.J., Yu, M.W., and Liaw, Y.F. (1997). Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12, S294-S308.
5. Chen, S., He, Y., Ding, J., Jiang, Y., Jia, S., Xia, W., Zhao, J., Lu, M., Gu, Z., and Gao, Y. (2010). An insertion=deletion polymorphism in the 3' untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem Biophys Res Commun 391, 552-556.
6. Ferrara, N. (2002).VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2, 795-803.
7. Fidler, I.J., Yano, S., Zhang, R.D., Fujimaki, T., and Bucana, C.D. (2002). The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3, 53-57.
8. Gao, Y., He, Y., Ding, J., Wu, K., Hu, B., Liu, Y., Wu, Y., Guo, B., Shen, Y., Landi, D., Landi, S., Zhou, Y., and Liu, H. (2009). An insertion=deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 30, 2064-2069.
9. Iavarone, M., Lampertico, P., Iannuzzi, F., Manenti, E., Donato, M.F., Arosio, E., Bertolini, F., Primignani, M., Sangiovanni, A., and Colombo, M. (2007). Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. J Viral Hepat 14, 133-139.
10. Kaseb, A.O., Hanbali, A., Cotant, M., Hassan, M.M., Wollner, I., and Philip, P.A. (2009). Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature. Cancer 115, 4895-4906.
11. Kong, S.Y., Park, J.W., Lee, J.A., Park, J.E., Park, K.W., Hong, E.K., and Kim, C.M. (2007). Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients. Hepatology 46, 446-455.
12. McGlynn, K.A., Tsao, L., Hsing, A.W., Devesa, S.S., and Frau-meni, J.F., Jr. (2001). International trends and patterns of primary liver cancer, Int J Cancer 94, 290-296.
13. Park, Y.N., Kim, Y.B., Yang, K.M., and Park, C. (2000). Increased expression of vascular endothelial growth factor and angio-genesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 124, 1061-1065.
14. Schneider, B.P., Radovich, M., and Miller, K.D. (2009).The role of vascular endothelial growth factor genetic variability in cancer. Clin Cancer Res 15, 5297-5302.
15. Shahbazi, M., Fryer, A.A., Pravica, V., Brogan, I.J., Ramsay, H.M., Hutchinson, I.V., and Harden, P.N. (2002). Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13, 260-264.
16. Stein, I., Itin, A., Einat, P., Skaliter, R., Grossman, Z., and Keshet, E. (1998). Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 18, 3112-3119.
17. Stevens, A., Soden, J., Brenchley, P.E., Ralph, S., and Ray, D.W. (2003). Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63, 812-816.
18. Suzuki, K., Hayashi, N., Miyamoto, Y., Yamamoto, M., Ohkawa, K., Ito, Y., Sasaki, Y., Yamaguchi, Y., Nakase, H., Noda, K., Enomoto, N., Arai, K., Yamada, Y., Yoshihara, H., Tujimura, T., Kawano, K., Yoshikawa, K., and Kamada, T. (1996). Expression of vascular permeability factor=vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56, 3004-3009.
19. Walsh, P.S., Metzger, D.A., and Higuchi, R. (1991). Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10, 506-513.
20. Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Hicklin, D.J., Wu, Y., Yanase, K., Namisaki, T., Kitade, M., Yamazaki, M., Tsujinoue, H., Masaki, T., and Fukui, H. (2004). Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. Hepatology 39, 1517-1524.
21. Yuan, Q., Zuo, X., and Jia, J. (2009). Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among Northern Chinese Han. Neurosci Lett 457, 133-136.